New Development in Pharmacotherapy of Kidney Diseases
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 April 2025 | Viewed by 64
Special Issue Editor
Interests: chronic kidney disease (CKD); acute kidney injury (AKI); cardiovascular protection; kidney protection
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit your research papers for a Special Issue of our journal, focusing on recent advances in pharmacotherapy for patients with kidney disease. This Special Issue aims to highlight the latest developments and innovations in the treatment of patients with both chronic and acute kidney disease, with an emphasis on cardiovascular and kidney protection, as well as the improvement of quality of life. Additionally, it will cover therapies that benefit bone health, endocrine function, electrolyte/mineral balance, gastrointestinal health, hematology, metabolism, neuromuscular function, and nutrition. We also welcome submissions on therapies that address specific symptoms and procedures related to kidney disease, such as uremic pruritus and the survival of dialysis access. We believe that your contributions will significantly enhance the understanding and management of kidney disease, ultimately improving patient outcomes and quality of life. We look forward to receiving your submissions and to the valuable insights your research will bring to this Special Issue.
Dr. Chihchao Yang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic kidney disease (CKD)
- acute kidney injury (AKI)
- pharmacotherapy
- cardiovascular protection
- kidney protection
- bone health
- endocrine function
- gut health
- metabolism
- neuromuscular function
- nutrition
- symptom management
- sodium-glucose cotransporter-2 (SGLT-2) inhibitors
- glucagon-like peptide-1 (GLP-1) receptor agonists
- non-steroidal mineralocorticoid receptor antagonists (MRA)
- endothelin receptor antagonists
- anemia management
- electrolyte abnormalities
- dialysis
- nephrotoxicity
- drug interactions
- uremic toxin
- clinical trials
- innovative therapies
- protein-energy wasting
- chronic kidney disease and bone mineral disease
- inflammation
- oxidation
- diabetes
- hypertension
- obesity
- hyperlipidemia
- pruritus
- osteoporosis
- fracture
- sarcopenia
- protein-energy wasting
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
